TC
LH icon

Trilogy Capital’s Labcorp LH Stock Holding History

Trilogy Capital’s Portfolio LH Stock Details LH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,049
Closed -$238K – 321
2023
Q4 		$238K Sell
1,049
-221
-17% -$46.4K 0.01% 236
2023
Q3 		$255K Sell
1,270
-392
-24% -$82.7K 0.02% 222
2023
Q2 		$313K Buy
1,662
+143
+9% +$27.7K 0.02% 223
2023
Q1 		$299K Buy
+1,519
New +$313K 0.02% 212

Other funds holding LH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
Diamond Hill Capital Management
Diamond Hill Capital Management Columbus, Ohio $12.5B AUM 7.49% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Trilogy Capital's LH Position: Q1 2024 in Review

Trilogy Capital sold out of Labcorp (LH) in Q1 2024, closing a stake of 1,049 shares — an estimated $238K sold.

Trilogy Capital first reported a position in LH in Q1 2023 and held it in 4 quarters. The position peaked at $313K in Q2 2023. 927 funds tracked by Wall St. Rank hold LH as of Q1 2024.

  • Trilogy Capital reported no remaining Labcorp position as of Q1 2024 after selling out during the quarter.
  • Trilogy Capital sold 1,049 Labcorp shares in Q1 2024, an estimated $238K.
  • Trilogy Capital first reported a position in Labcorp in Q1 2023 and held it in 4 quarters.
  • Trilogy Capital's Labcorp position peaked at $313K in Q2 2023.
  • 927 funds tracked by Wall St. Rank held Labcorp as of Q1 2024.

Based on Trilogy Capital's 13F filing for Q1 2024, filed 17 Apr 2024.